BS_QV51J756
Ganglioglioma
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- Ganglioglioma
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- Ganglioglioma
- overall_survival_months
- 17.608409986859396
- age_years
- 9.512
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
3 twins match this tumor's tissue · 7 come from a different tissue of origin ← cross-tissue dominant
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | BS_ZR96A4FH | DNET | — | 0.986 |
| 2 | BS_C7N3J4NW | high-grade glioma | — | 0.965 |
| 3 | BS_6MY8W3H0 | DNET | — | 0.964 |
| 4 | BS_7B89YR6K | EPN | Posterior Fossa EPN | 0.963 |
| 5 | BS_92VDQ0NE | Ganglioglioma | — | 0.962 |
| 6 | BS_KPT2WPHW | Ganglioglioma | — | 0.961 |
| 7 | BS_7B89YR6K | Posterior Fossa Ependymoma | — | 0.960 |
| 8 | SRR1472323 | GTEX | — | 0.957 |
| 9 | BS_K5802F84 | pilocytic astrocytoma | — | 0.955 |
| 10 | BS_QF5VVZX5 | Ganglioglioma | — | 0.950 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 14 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| KRAS_SIGNALING_DN | 0.460 | Remibrutinib | — uncovered |
| PANCREAS_BETA_CELLS | 0.350 | Cobimetinib | — uncovered |
| APICAL_SURFACE | 0.317 | Temsirolimus | — uncovered |
| MYOGENESIS | 0.307 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.261 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.221 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.166 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.158 | Inavolisib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.153 | Idelalisib | — uncovered |
| COAGULATION | 0.121 | Binimetinib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.112 | Inavolisib | — uncovered |
| APICAL_JUNCTION | 0.082 | Inavolisib | — uncovered |
| KRAS_SIGNALING_UP | 0.057 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.004 | Idelalisib | — uncovered |